NK T cell-induced protection against diabetes in Vα14-Jα281 transgenic nonobese diabetic mice is associated with a Th2 shift circumscribed regionally to the islets and functionally to islet autoantigen

Journal of Immunology

Volumn 166, Issue 6, 2001, Pages 3749-3756

  Laloux, V ^a   Beaudoin, L ^a   Jeske, D ^a   Carnaud, C ^a   Lehuen, A ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; CYTOKINE; GLUTAMATE DECARBOXYLASE; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; INTERLEUKIN 12; INTERLEUKIN 4; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIABETES MELLITUS; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IMMUNE RESPONSE; IMMUNOREGULATION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PANCREAS ISLET; PRIORITY JOURNAL; TH2 CELL; TRANSGENIC MOUSE;

EID: 0035869449     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.6.3749     Document Type: Article

References (44)

1. Insulin-dependent diabetes mellitus as an autoimmune disease
2. + T cells
3. The nonobese diabetic mouse as a model of autoimmune diabetes: Immune dysregulation gets the NOD
4. Acceleration of the onset of diabetes in NOD mice by thymectomy at weaning
5. T cell-mediated inhibition of the transfer of autoimmune diabetes in NOD mice
6. - (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10
7. Overexpression of natural killer T cells protects Vαl4-Jα281 transgenic nonobese diabetic mice against diabetes
8. Mouse CDI-specific NK1 T cells: Development, specificity, and function
9. - T cells in mice and humans
10. +T lymphocytes
11. CD1d-restricted and TCR-mediated activation of vαd4 NKT cells by glycosylceramides
12. Selective ability of mouse CD1 to present glycolipids: α-galactosylceramide specifically stimulates Vαl4+ NK T lymphocytes
13. Natural ligand of mouse CD1d1: Cellular glycosylphosphatidylinositol
14. CD1d-restricted immunoglobulin G formation to GPI-anchored antigens mediated by NKT cells
15. 1pos T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3
16. + T cells in a TH2 response and in immunoglobulin E production
17. Increased interleukin 4 and immunoglobulin E production in transgenic mice overexpressing NKIT cells
18. + T cells induces monocyte chemoattractant protein-1 in early listeriosis
19. + effector function against intracellular infection
20. + TCR αβ intermediate cells increase during experimental malaria infection and are able to exhibit inhibitory activity against the parasite liver stage in vitro
21. Requirement for Vα14 NKT cells in 1L-12-mediated rejection of tumors
22. Differential tumor surveillance by natural killer (NK) and NKT cells
23. +-like thymocytes in the NOD mouse
24. - T-cell deficiency and IDDM in NOD/Lt mice
25. Extreme Th1 bias of invariant Vα24JαQ T cells in type 1 diabetes
26. A versatile ELISA-PCR assay for mRNA quantitation from a few cells
27. Genetic characterization of mouse immunoglobulin allotypic determinants (allotopes) defined by monoclonal antibodies
28. Interleukin 12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice
29. The interleukin-12/interleukin-12-receptor system: Role in normal and pathologic immune responses
30. Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice
31. IL-4 prevents insulitis and insulin-dependent diabetes mellitus in nonobese diabetic mice by potentiation of regulatory T helper-2 cell function
32. Pancreatic expression of interleukin-4 abrogates insulitis and autoimmune diabetes in nonobese diabetic (NOD) mice
33. Cutting edge: Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells
34. α-Galactosylceramide-activated Vα14 natural killer T cells mediate protection against murine malaria
35. Immunization with alphagalactosylceramide polarizes CD1-reactive NK T cells towards Th2 cytokine synthesis
36. Cutting edge: Activation of NK T cells by CDld and α-galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype
37. Inhibition of T helper cell type 2 cell differentiation and immunoglobulin E response by ligand-activated Vα14 natural killer T cells
38. Initiation of autoimmune diabetes by developmentally regulated presentation of islet cell antigens in the pancreatic lymph nodes
39. Cross-tolerance: A pathway for inducing tolerance to peripheral tissue antigens
40. + naturally anergic and suppressive T cells: Induction of autoimmune disease by breaking their anergic/suppressive state
41. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production
42. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis
43. A defect in interleukin 12-induced activation and interferon γ secretior of peripheral natural killer T cells in nonobese diabetic mice suggests new pathogenic mechanisms for insulin-dependent diabetes mellitus
44. Rapid death and regeneration of NKT cells in anti-CD3ε- or IL-12-treated mice: A major role for bone marrow in NKT cell homeostasis